NovoLogix user interface update: Old version of authorization screen to be deactivated March 1
Starting March 1, 2022, the old version of the NovoLogix authorization screen will be deactivated and the new version of the screen will open automatically for all providers. This is part of an upgrade to the NovoLogix user interface.
The new authorization screen has been available since 2020 and most providers are already using it.
Action to take
Providers who are still using the old authorization screen should switch to the new screen before March 1. To do this, click the New Screen check box in the upper-right corner of the old screen.
Benefits of new authorization screen
The new authorization screen streamlines the process of creating authorization requests. The main features include:
The NovoLogix online tool is used to submit prior authorization requests for some medical benefit drugs for Blue Cross Blue Shield of Michigan commercial members, Medicare Plus BlueSM, Blue Care Network commercial and BCN AdvantageSM members.
As a reminder, you can find information about medical benefit drugs that require prior authorization on these webpages at ereferrals.bcbsm.com:
Posted: January 2022
Lines of business: Blue Cross Blue Shield of Michigan and Blue Care Network